ClinicalTrials.gg
CompletedNCT03333850TAPASUpdated Dec 7, 2018

Technology Assisted Physical Activity Among Hospitalised Patients With Respiratory Disease

An interventional study of Visual feedback of physical activity and No feedback of physical activity in Respiratory Disease, sponsored by Marius Henriksen. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-12-07.

Sponsored by Marius Henriksen · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of this study is to investigate if patients hospitalised for medical disease will increase their time spent out of bed during hospitalisation through simple feedback about physical activities from a mobile device.

Physical activity is measured by means of a pair of accelerometers embedded in band aids placed on the thigh and on the chest. The measurement is continuous and data is uploaded to a secure internet-server. Summaries of physical activity (bedrest, sitting, standing, walking) is computed and can be displayed on a mobile device (tablet) through a dedicated application.

The study will be conducted as a controlled cohort study in a large tertiary public hospital in Copenhagen, Denmark. Patients admitted to Department of Respiratory Medicine will be included and will have their physical activity measured during hospitalisation. Half of the cohort will receive visual feedback about the amount of physical activity from a mobile device placed on the bed table.

A total of 108 patients will be included resulting in 6 periods of 18 patients each.

02

Conditions studied

  • Respiratory Disease

Browse trials for

03

In context

Respiration Disorders

359 studies on the registry are indexed under Respiration Disorders; 64 are open to participants now.

This study's enrollment of 96 is above the median of 69 across 216 interventional studies indexed under Respiration Disorders.

Browse Respiration Disorders studies →

Lead sponsor

Marius Henriksen is the lead sponsor of 18 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Is admitted to the Department of Respiratory Medicine
  2. Has signed
  3. Reads and speaks Danish

Exclusion criteria

Exclusion Criteria:

  1. Any condition that, in the opinion of the investigator, makes the person unfit for participation
  2. Has allergy towards band aid
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
96 participants (actual)

Study arms

  • Experimental
    Visual feedback of physical activity

    Participants in the exposure cohort will receive usual hospital care and continuous measurement of physical activity by sensors collecting physical activity level during hospitalisation AND a monitor placed at their bedside that displays information about their physical activity level, in terms of time spent bedridden, sitting, standing and walking. This information will be visible to the health personnel, the patients and their relatives.

    Device: Visual feedback of physical activity · Device: Measurement of physical activity

  • Active comparator
    No feedback of physical activity

    The participants in the non-exposure cohort will receive usual hospital care and continuous measurement of physical activity by sensors collecting physical activity level during hospitalisation. No visual feedback is provided.

    Device: No feedback of physical activity · Device: Measurement of physical activity

Interventions

  • DeviceVisual feedback of physical activity

    A monitor (tablet) will display the level of physical activity during hospitalisation. The monitor will be placed at the bedside (table).

  • DeviceNo feedback of physical activity

    There will be no visual feedback of the physical activity (no monitor placed at the bedside (table)).

  • DeviceMeasurement of physical activity

    A pair of accelerometers placed on the chest and on the thigh will measure the physical activity level during hospitalisation. The measurement is made continuously and stored on a secure web-server.

06

What researchers measure

Primary outcomes

  1. Time spent out of bed during hospitalisation

    Time (in minutes) spent out of bed measured in minutes related to the total hospitalisation time. The time spent out of bed will be recorded throughout the hospitalisation for a maximum of 7 days.

    Time frame: 7 Days

Secondary outcomes

  1. Time spent sitting during hospitalisation

    Time (in minutes) spent sitting related to the total hospitalisation time. The time sitting will be recorded throughout the hospitalisation for a maximum of 7 days.

    Time frame: 7 Days

  2. Time spent standing during hospitalisation

    Time (in minutes) spent standing related to the total hospitalisation time. The time standing will be recorded throughout the hospitalisation for a maximum of 7 days.

    Time frame: 7 Days

  3. Time spent walking during hospitalisation

    Time (in minutes) spent walking related to the total hospitalisation time. The time walking will be recorded throughout the hospitalisation for a maximum of 7 days.

    Time frame: 7 Days

Other outcomes

  1. Mortality

    Mortality at any time during hospitalisation will be recorded.

    Time frame: 7 Days

07

Study locations

1 site
  • Bispebjerg Hospital, Department of Physical and Occupational Therapy
    Copenhagen, 2400, Denmark
08

References and documents

Individual participant data

Plan to share: Yes — When data has been anonymised, analysed, and the scientific report(s) published, the data will be made available to other researchers. Availability will be through direct contact to the study director or principal investigator.

Supporting information: Study protocol, Statistical analysis plan, Clinical study report

Time frame: When data has been anonymised, analysed, and the scientific report(s) published.

Access criteria: The are no criteria specified at this time

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2017 to primary completion in Jun 2018, 7 months.

Of 91 non-industry interventional studies with no phase under Respiration Disorders, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 37. This study's 7 months is below that.

Counting every sponsor, half of 111 studies reached it within 18 months; a quarter within 7 and three quarters within 35.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 30, 2017
First posted
Nov 7, 2017
StartActual
Nov 8, 2017
Primary completionActual
Jun 30, 2018
CompletionActual
Jun 30, 2018
Last update
Dec 7, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03333850
Lead sponsor
Marius Henriksen
Responsible party
Marius Henriksen (Professor, Frederiksberg University Hospital) — Sponsor-investigator
First posted
Nov 7, 2017
Start date
Nov 8, 2017
Primary completion
Jun 30, 2018
Completion
Jun 30, 2018
Last update
Dec 7, 2018

Study contacts

Christian H Dall, PhD
study director · Department of Physio- and Occupational Therapy, Bispebjerg-Frederiksberg Hospital, Denmark
Marius Henriksen, PhD
principal investigator · Department of Physio- and Occupational Therapy, Bispebjerg-Frederiksberg Hospital, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion